Portal de Periódicos da CAPES

Severe refractory COVID-19 patients responding to convalescent plasma; A case series

2020; Wolters Kluwer; Volume: 56; Linguagem: Inglês

10.1016/j.amsu.2020.06.018

2049-0801

Hadi Mohammed Abdullah, Hersh H. Hama-Ali, Sabah Nasraddin Ahmed, Kosar Muhammad Ali, Kamaran Karadakhy, Safeen Othman Mahmood, Zana H. Mahmood, Karmand Qadir Hamad Amin, Peshnyar Muhammad Atta, Bryar Ezadeen Nuradeen, Shvan H. Mohammed, Rawezh Q. Salih, Hiwa O. Baba, Fahmi H. Kakamad,

COVID-19 Impact on Reproduction

Although some medicines are under research, currently, no specific antiviral drug has been approved to target 2019 novel coronavirus. In this report two severe cases of 2019 novel coronavirus disease (COVID-19) patients have been described who received convalescent plasma (CP).